Healthcare Triangle, Inc. (HCTI)

NASDAQ: HCTI · Real-Time Price · USD

2.450

-0.080 (-3.16%)

At close: Apr 16, 2026, 4:00 PM EDT

2.450

0.00 (0.00%)

Pre-market: Apr 17, 2026, 7:00 AM EDT

Healthcare Triangle Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Healthcare Triangle in the last 12 months.

Price Target: n/a

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Healthcare Triangle.

Recommendation Trends

Rating	Jul '22	Aug '22
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Constantine Davides EF Hutton	EF Hutton	Strong Buy Maintains $597,600 → $298,800	Strong Buy	Maintains	$597,600 → $298,800	+12,195,818.37%	Sep 28, 2022
Constantine Davides EF Hutton	EF Hutton	Strong Buy Initiates $597,600	Strong Buy	Initiates	$597,600	+24,391,736.73%	Mar 14, 2022

Financial Forecast

Revenue This Year

24.91M

from 13.89M

79.33%

from 13.89M

Revenue Next Year

29.89M

from 24.91M

20.00%

from 24.91M

EPS This Year

-54.06

from -

EPS Next Year

-22.44

from -54.06

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	35.27M	45.89M	33.20M	11.70M	13.89M	24.91M	29.89M
Revenue Growth	12.54%	30.10%	-27.64%	-64.77%	18.77%	79.33%	20.00%
EPS	-	-	-	-	-	-54.06	-22.44
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	25.6M	30.8M
Avg	24.9M	29.9M
Low	23.9M	28.7M

Revenue Growth

Revenue Growth	2026	2027
High	84.6%	23.5%
Avg	79.3%	20.0%
Low	72.3%	15.3%

EPS Forecast

EPS	2026	2027
High	-55.65	-23.10
Avg	-54.06	-22.44
Low	-51.94	-21.56

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.